BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27942862)

  • 1. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
    Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection.
    Hilgendorf I; Mueller-Hilke B; Kundt G; Holler E; Hoffmann P; Edinger M; Freund M; Wolff D
    Transpl Int; 2012 Jan; 25(1):87-96. PubMed ID: 22098606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hu Y; Cui Q; Ye Y; Luo Y; Tan Y; Shi J; Huang H
    Hematol Oncol; 2017 Mar; 35(1):118-124. PubMed ID: 26439896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
    Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune cell subset counts associated with graft-versus-host disease.
    Podgorny PJ; Liu Y; Dharmani-Khan P; Pratt LM; Jamani K; Luider J; Auer-Grzesiak I; Mansoor A; Williamson TS; Ugarte-Torres A; Hoegh-Petersen M; Stewart DA; Daly A; Khan FM; Russell JA; Storek J
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):450-62. PubMed ID: 24406506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool.
    Fukunaga A; Ishikawa T; Kishihata M; Shindo T; Hori T; Uchiyama T
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1176-84. PubMed ID: 17889354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.
    Li Q; Zhai Z; Xu X; Shen Y; Zhang A; Sun Z; Liu H; Geng L; Wang Y
    Leuk Res; 2010 Sep; 34(9):1158-68. PubMed ID: 20409584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T memory stem cells after allogeneic haematopoietic cell transplantation: unique long-term kinetics and influence of chronic graft-versus-host disease.
    Jimbo K; Konuma T; Watanabe E; Kohara C; Mizukami M; Nagai E; Oiwa-Monna M; Mizusawa M; Isobe M; Kato S; Takahashi S; Tojo A
    Br J Haematol; 2019 Sep; 186(6):866-878. PubMed ID: 31135974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between immune reconstitution and chronic graft-versus-host disease after unrelated cord blood transplantation and sibling peripheral blood stem cell transplantation].
    Wang J; Pan TZ; Huang PP; Sun ZM; Zhu HP
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):466-473. PubMed ID: 34384152
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning.
    Poloni A; Sartini D; Emanuelli M; Trappolini S; Mancini S; Pozzi V; Costantini B; Serrani F; Berardinelli E; Renzi E; Olivieri A; Leoni P
    Cytokine; 2011 Mar; 53(3):376-83. PubMed ID: 21211989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
    Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
    Front Immunol; 2019; 10():1879. PubMed ID: 31507582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
    Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
    Gooptu M; Kim HT; Chen YB; Rybka W; Artz A; Boyer M; Johnston L; McGuirk J; Shea TC; Jagasia M; Shaughnessy PJ; Reynolds CG; Fields M; Alyea EP; Ho VT; Glavin F; Dipersio JF; Westervelt P; Ritz J; Soiffer RJ
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2216-2223. PubMed ID: 30006305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation.
    Tsutsumi Y; Tanaka J; Miura Y; Toubai T; Kato N; Fujisaw F; Toyoshima N; Ota S; Mori A; Yonezumi M; Chiba K; Kondo T; Hasino S; Kobayasi R; Masauji N; Kasai M; Asaka M; Imamura M
    Leuk Lymphoma; 2004 Mar; 45(3):481-8. PubMed ID: 15160909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.